Patents by Inventor Stephani Velasquez

Stephani Velasquez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING NEURODEGENERATIVE DISEASES BY TARGETING THE PURINERGIC AND/OR ADENOSINE RECEPTORS
    Publication number: 20220080027
    Abstract: The present disclosure provides methods to reduce and/or increase the function of the purinergic/Adenosine system in individuals with detected cognitive impairment such as Alzheimer's, Parkinson's, and HIV as well as other diseases with dysregulated ATP secretion and its degradation products including adenosine. The present disclosure provides methods to block the toxic effects of increased circulating levels of ATP observed in several kinds of CNS diseases and maybe peripherical diseases.
    Type: Application
    Filed: September 16, 2021
    Publication date: March 17, 2022
    Inventors: Eliseo Eugenin, Jonathan Geiger, Stephani Velasquez
  • Modulation of NAD+ metabolic pathways for treatment of disease
    Patent number: 10722529
    Abstract: The present invention encompasses compositions and methods for regulating the kynurenine to tryptophan ratio, NAD+ level and CD16 expression for the treatment diseases.
    Type: Grant
    Filed: December 2, 2016
    Date of Patent: July 28, 2020
    Assignee: Temple University—Of The Commonwealth System of Higher Education
    Inventors: Jay F. Rappaport, Xuebin Qin, Stephani Velasquez
  • MODULATION OF NAD+ METABOLIC PATHWAYS FOR TREATMENT OF DISEASE
    Publication number: 20180353526
    Abstract: The present invention encompasses compositions and methods for regulating the kynurenine to tryptophan ratio, NAD+ level and CD16 expression for the treatment diseases.
    Type: Application
    Filed: December 2, 2016
    Publication date: December 13, 2018
    Inventors: Jay F. Rappaport, Xuebin Qin, Stephani Velasquez